Jonathan Katz

Mr. Jonathan Katz


Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2012 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MHMark R Hutchinson
Mark R Hutchinson
ANA. L. Northcutt
A. L. Northcutt
THT. Hiranita
T. Hiranita
XWXiaohui Wang
Xiaohui Wang
SLS. S. Lewis
S. S. Lewis
LWL. R. Watkins
L. R. Watkins
Opioid action was thought to exert reinforcing effects solely via the initial agonism of opioid receptors. Here, we present evidence for an additional novel contributor to opioid reward: the innate immune pattern-recognition receptor, toll-like receptor 4 (TLR4), and its MyD88-dependent signaling. Blockade of TLR4/MD2 by administration of the nonopioid, unnatural isomer of naloxone, (+)-naloxone (rats), or two independent genetic knock-outs of MyD88-TLR4-dependent signaling (mice), suppressed opioid-induced conditioned place preference. (+)-Naloxone also reduced opioid (remifentanil) self-administration (rats), another commonly used behavioral measure of drug reward. Moreover, pharmacological blockade of morphine-TLR4/MD2 activity potently reduced morphine-induced elevations of extracellular dopamine in rat nucleus accumbens, a region critical for opioid reinforcement. Importantly, opioid-TLR4 actions are not a unidirectional influence on opioid pharmacodynamics, sinceTLR4−/−mice had reduced oxycodone-induced p38 and JNK phosphorylation, while displaying potentiated analgesia. Similar to our recent reports of morphine-TLR4/MD2 binding, here we provide a combination ofin silicoand biophysical data to support (+)-naloxone and remifentanil binding to TLR4/MD2. Collectively, these data indicate that the actions of opioids at classical opioid receptors, together with their newly identified TLR4/MD2 actions, affect the mesolimbic dopamine system that amplifies opioid-induced elevations in extracellular dopamine levels, therefore possibly explaining altered opioid reward behaviors. Thus, the discovery of TLR4/MD2 recognition of opioids as foreign xenobiotic substances adds to the existing hypothesized neuronal reinforcement mechanisms, identifies a new drug target in TLR4/MD2 for the treatment of addictions, and provides further evidence supporting a role for central proinflammatory immune signaling in drug reward.

1 June 1992 in Pharmacological Reviews
Verified
Journal Article
Closed access
JWJ H Woods
J H Woods
JKJonathan Katz
Jonathan Katz
GWG Winger
G Winger

15 April 2003 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
JKJonathan Katz
Jonathan Katz
SHStephen T. Higgins
Stephen T. Higgins

3 February 2015 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
ANA L Northcutt
A L Northcutt
MHMark R Hutchinson
Mark R Hutchinson
XWX Wang
X Wang
MBM V Baratta
M V Baratta
THT Hiranita
T Hiranita
LWL R Watkins
L R Watkins
The initial reinforcing properties of drugs of abuse, such as cocaine, are largely attributed to their ability to activate the mesolimbic dopamine system. Resulting increases in extracellular dopamine in the nucleus accumbens (NAc) are traditionally thought to result from cocaine’s ability to block dopamine transporters (DATs). Here we demonstrate that cocaine also interacts with the immunosurveillance receptor complex, Toll-like receptor 4 (TLR4), on microglial cells to initiate central innate immune signaling. Disruption of cocaine signaling at TLR4 suppresses cocaine-induced extracellular dopamine in the NAc, as well as cocaine conditioned place preference and cocaine self-administration. These results provide a novel understanding of the neurobiological mechanisms underlying cocaine reward/reinforcement that includes a critical role for central immune signaling, and offer a new target for medication development for cocaine abuse treatment.

1 August 1995 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
CFC Fischer
C Fischer
GHG Hatzidimitriou
G Hatzidimitriou
JWJ Wlos
J Wlos
JKJonathan Katz
Jonathan Katz
GRG Ricaurte
G Ricaurte
The recreational drug (+/)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) is a methamphetamine derivative that selectively destroys central 5-HT axons and axon terminals in animals and, possibly, humans. The fate of 5-HT neurons following MDMA injury is uncertain. In particular, while it is known that central 5-HT axons can undergo regenerative sprouting after MDMA injury, it has not been determined whether they reestablish the original innervation pattern. To address this question, the present studies examined 5-HT innervation patterns in animals lesioned with MDMA 12–18 months previously. Both rodents (rats) and nonhuman primates (squirrel monkeys) were examined, since there is indication that serotonergic recovery after MDMA injury may be species dependent. 5-HT axon projections were studied neurochemically, autoradiographically and immunocytochemically. In both rodents and nonhuman primates previously lesioned with MDMA, substantial serotonergic axonal sprouting was observed. However, in a few rats and in most squirrel monkeys, the reinnervation pattern was highly abnormal: distant targets (e.g., dorsal neocortex) remained denervated, while some proximal targets (e.g., amygdala, hypothalamus) were reinnervated or hyperinnervated. Although the specific determinants of axonal recovery after MDMA injury remain to be identified, it appears that axons which initially sustain more severe damage, are longer, or are more highly arborized have low probability of recovering. The observation that some brain regions remain denervated, while others are reinnervated or hyperinnervated suggests that, under some circumstances, MDMA injury can lead to a lasting reorganization of ascending 5-HT axon projections. Such lasting changes in brain innervation, documented here in MDMA-treated animals, may have implications for humans using MDMA recreationally.

20 December 2006 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JZJianhua Zhang
Jianhua Zhang
LZLu Zhang
Lu Zhang
HJHongyuan Jiao
Hongyuan Jiao
QZQi Zhang
Qi Zhang
DZDongsheng Zhang
Dongsheng Zhang
MXMing Xu
Ming Xu
Development of drug addiction involves persistent neurobiological changes. The dopamine D1receptor is involved in mediating cocaine-induced neuroadaptation, yet the underlying intracellular mechanisms remain unclear. We examined a potential role of the immediate early geneFos, which is robustly and rapidly induced by cocaine via D1receptors, in mediating cocaine-induced persistent neurobiological changes by creating and analyzing a mouse in whichFosis primarily disrupted in D1receptor-expressing neurons in the brain. We show that the expression levels of several transcription factors, neurotransmitter receptors, and intracellular signaling molecules induced by repeated cocaine administration are altered inFos-deficient brains. Dendritic remodeling of medium spiny neurons induced by repeated exposure to cocaine is blunted in the mutant mice. The mutant mice exhibit attenuated behavioral sensitization after repeated exposure to cocaine and more persistent memory of cocaine-induced conditioned place preference. Our findings indicate that c-Fos produced in D1receptor-expressing neurons integrates mechanisms to facilitate both the acquisition and extinction of cocaine-induced persistent changes.